Company intelligence / Profile preview

Staar Surgical

Monrovia, California, United Statesstaar.com ↗

Ownership: Private
Employees: ~900
Development stage: Commercial

Overview

Staar Surgical’s EVO ICL™ and Visian ICL® family of implantable collamer lenses are approved and marketed globally for the correction of myopia, hyperopia, astigmatism, and cataracts. Over three million lenses have been implanted worldwide with high patient satisfaction (>99%). The company continues to innovate with new models and delivery systems.

Therapeutic areas: Ophthalmology
Modalities: Device (specifically implantable lenses)Biologic (Collamer® material used in some lenses)
Industry: Implantable Medical Devices

Drug pipeline

3 assets

EVO ICL

Commercial

Indications: Myopia, Hyperopia, Astigmatism

2 more assets in the full pipeline.

Partnerships

Not specifically listed; distributes through own sales force & independent distributors globally. No major pharma partnerships disclosed.

Beyond the preview

Go deeper on Staar Surgical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Staar Surgical.